Stock Market 27 May 2026 - 28 May 2026

NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus
····

NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus

NewAmsterdam Pharma shares rose 1.3% to $36.56 Wednesday after Chief Accounting Officer Louise Frederika Kooij exercised and sold 65,000 shares, according to a Form 4 filing. A separate Form 144 listed a proposed sale of 210,000 shares for Kooij. The company awaits key regulatory decisions on its cholesterol drug obicetrapib later this year. NewAmsterdam reported a first-quarter net loss of $48.4 million.
May 28, 2026
Capitol Federal Stock Nears a 52-Week High as Traders Watch Margins, Buybacks
····

Capitol Federal Stock Nears a 52-Week High as Traders Watch Margins, Buybacks

Capitol Federal Financial shares rose to $7.80 in premarket trading Thursday after closing at $7.77, near a 52-week high. The Topeka-based bank reported fiscal Q2 net income of $20.1 million and a net interest margin of 2.24%. Commercial loans increased $39.1 million to $2.32 billion. The company repurchased 3.08 million shares and declared an 8.5-cent dividend.
May 28, 2026
DNA X Stock Looks at Nasdaq Deadline After Latest Financing
····

DNA X Stock Looks at Nasdaq Deadline After Latest Financing

DNA X said Nasdaq will delist its shares after the company fell short of stockholders’ equity rules, posting a $983,000 deficit for the March quarter. The company plans to request a hearing by May 29 to halt suspension as it appeals. DNA X shares last traded at $4.07 in premarket, valuing the firm at about $5.1 million. The company also announced a $3.05 million convertible note financing.
May 28, 2026
Carter Bankshares rally cools for now as market looks for next move
····

Carter Bankshares rally cools for now as market looks for next move

Carter Bankshares closed down 1.9% at $26.84 Wednesday, reversing part of a recent rally that brought shares near a 52-week high. Trading volume fell to 217,125 shares from 254,683 the day before. Executive vice president Jane Ann Davis sold 261 shares at $26.95 on May 21, leaving her with 13,723 shares. Carter reported first-quarter net income of $85.8 million after selling a large nonperforming loan.
May 28, 2026
Nuvve Slips Under $1 As Nasdaq Deadline Nears
····

Nuvve Slips Under $1 As Nasdaq Deadline Nears

Nuvve Holding Corp. last traded at 36.27 cents, still below Nasdaq’s $1 minimum, with a Friday deadline to avoid delisting. Nasdaq cited both the low share price and a late quarterly filing as reasons for possible removal. Nuvve plans to request a stay of suspension by May 29. The company reported a $31.5 million net loss for 2025 and warned of “substantial doubt” about its ability to continue operating.
May 28, 2026
Krystal Biotech Near Highs After Insider Filing Ahead of 2026 Data
····

Krystal Biotech Near Highs After Insider Filing Ahead of 2026 Data

Krystal Biotech EVP Thomas John Charles sold 642 shares at $302.03 each on May 26, leaving him with no directly held common stock, according to an SEC filing. KRYS traded at $306.63, near its 52-week high, with the company valued around $9.35 billion. VYJUVEK, Krystal’s gene therapy for DEB, posted Q1 revenue of $116.4 million. Two late-stage readouts are expected this year.
May 28, 2026
Falcon’s Beyond Stock Drops After Nasdaq Preferred Listing Raises Cash Questions
····

Falcon’s Beyond Stock Drops After Nasdaq Preferred Listing Raises Cash Questions

Falcon’s Beyond Global shares fell 60 cents to $14.73 in after-hours trading Wednesday after a new preferred-stock listing and ongoing cash concerns. The company reported $5.4 million in first-quarter revenue and $6.1 million in net income, but flagged “substantial doubt” about its ability to continue due to $1.2 million in cash and $9.3 million in short-term debt.
May 28, 2026
Fathom Stock Slips Below $1 Again as Nasdaq Deadline and Late 10-Q Keep Investors Watching
····

Fathom Stock Slips Below $1 Again as Nasdaq Deadline and Late 10-Q Keep Investors Watching

Fathom Holdings shares fell 1.5% to $0.574 in late trading Wednesday, remaining below Nasdaq’s $1 minimum bid threshold as investors awaited a delayed first-quarter filing. The company has until Oct. 7 to regain compliance. Fathom filed for a five-day extension to complete its quarterly report, saying it did not expect significant changes from last year’s results.
May 28, 2026
Array Technologies Jumps 7% After Solar Stocks Bounce; $2.4B Order Book Gets Attention
····

Array Technologies Jumps 7% After Solar Stocks Bounce; $2.4B Order Book Gets Attention

Array Technologies shares jumped 7.24% to $9.03 Wednesday, outpacing the S&P 500 and Nasdaq, as solar stocks rallied. No new company update was issued; investors revisited Array’s May 6 report showing $2.4 billion in orders and first-quarter revenue of $223.4 million. Shoals, Nextpower, and First Solar also gained. The Invesco Solar ETF rose 2.2%.
May 27, 2026
1 … 4 5 6 7 8 … 126

Stock Market Today

  • FTSE Rises on Strength in Midcap Stocks Driving Market Confidence
    June 2, 2026, 7:51 AM EDT. The FTSE index gained momentum as midcap stocks led a resurgence in market confidence. Midcaps, companies with medium-sized market capitalization, showed robust performance, contributing to the broader market's uplift. This shift reflects growing investor optimism amid current economic conditions. Market watchers highlight the midcap rally as a key driver of gains in the FTSE, signaling renewed investor interest and potential appetite for riskier assets within the London stock market.